Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(67%)
Results Posted
100%(1 trials)

Phase Distribution

Ph phase_4
1
33%
Ph phase_2
1
33%
Ph phase_3
1
33%

Phase Distribution

0

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 3Large-scale testing
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Completed(1)

Detailed Status

Recruiting1
Active, not recruiting1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (33.3%)
Phase 31 (33.3%)
Phase 41 (33.3%)

Trials by Status

recruiting133%
active_not_recruiting133%
completed133%

Recent Activity

2 active trials
Showing 3 of 3
recruitingphase_3

A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the Ankle

NCT06915233
active_not_recruitingphase_4

PRP vs AD-SVF in Addition to Marrow Stimulation for Knee Chondral Lesion

NCT07255547
completedphase_2

Safety and Efficacy Study of Stem Cell Transplantation to Treat Dilated Cardiomyopathy

NCT00629018

Clinical Trials (3)

Showing 3 of 3 trials
NCT06915233Phase 3

A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the Ankle

Recruiting
NCT07255547Phase 4

PRP vs AD-SVF in Addition to Marrow Stimulation for Knee Chondral Lesion

Active Not Recruiting
NCT00629018Phase 2

Safety and Efficacy Study of Stem Cell Transplantation to Treat Dilated Cardiomyopathy

Completed

All 3 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
3